gestational trophoblastic disease

(redirected from Gestational trophoblastic diseases)
Also found in: Wikipedia.

hy·da·tid·i·form mole

, hydatid mole [MIM*231090]
a vesicular or polycystic mass resulting from the proliferation of the trophoblast, with hydropic degeneration and avascularity of the chorionic villi; the abnormal tissue typically results from expression of paternally derived chromosomes and a loss of maternal chromosomes.

gestational trophoblastic disease

A generic term for a group of pregnancy-related disorders that arise from the trophoblast and clinically range from banal (e.g., hydatidiform mole) to aggressively malignant (e.g., choriocarcinoma).

Gestational trophoblastic disease
Hydatidiform mole
• Complete mole
• Partial mole
• Invasive mole
Placental site trophoblastic tumour
Epithelioid trophoblastic tumour
Choriocarcinoma

gestational trophoblastic disease

Gynecology A general term for the proliferative processes arising in trophoblastic tissue in ♀ of child-bearing age Types Gestational trophoblastic tumor/neoplasia, molar pregnancy, choriocarcinoma. See Choriocarcinoma, Mole, Trophoblastic tumor.

Gestational trophoblastic disease

A rare, aggressive, malignant, often metastatic (spreading to other organs) cancer in women of childbearing age in which cancer cells grow in the tissues that are formed in the uterus after conception
References in periodicals archive ?
Epidemiology and aetiology of gestational trophoblastic diseases.
Hydatidiform mole is a part of generic term, Gestational Trophoblastic Disease (GTD).
Gestational trophoblastic disease among Hispanic women: a 21-year hospital-based study.
hCG is synthesized and secreted by trophoblastic tissue of the placenta in pregnancy, gestational trophoblastic diseases, and certain other pathological conditions (2-5).
Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Gestational trophoblastic diseases, 2: hyperglycosylated hCG as a reliable marker of active neoplasia.
Such cases have 3 potential etiologies: (a) false-positive hCG due to interfering antibodies, (b) quiescent gestational trophoblastic disease, and (c) pituitary hCG.
Gestational trophoblastic disease (GTD) consists of a variety of disorders that arise from placental trophoblastic tissue.
Gestational trophoblastic diseases (GTDs) are a heterogeneous group of diseases that include partial and complete hydatidiform moles (CHMs), invasive moles, choriocarcinomas, placental site trophoblastic tumors, and epithelioid trophoblastic tumors.
Management of gestational trophoblastic diseases in Japan-a review.
Additional serum samples were collected from 12 women erroneously diagnosed as having choriocarcinoma or gestational trophoblastic disease because of false-positive hCG results (16,17).
Analysis of serum samples from 12 patients erroneously diagnosed with choriocarcinoma or gestational trophoblastic disease based on false-positive hCG data (16).